NCT03440164View on ClinicalTrials.gov

Superior Silybin Bioavailability in Healthy Volunteers

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

November 11, 2016

Primary Completion Date

December 8, 2016

Study Completion Date

December 15, 2016

Conditions
Liver DiseasesChronic Liver Disease
Interventions
OTHER

Sylimarin and Sylibin

We compared the plasma levels of Silibinin after a dosage of Silibinin-phosphatidylcholine complex, equivalent to 45 mg Silybin oily-medium soft-gel capsules after the conventional 70-mg Silymarin tablets, in 23 healthy volunteers

All Listed Sponsors
lead

Medica Sur Clinic & Foundation

OTHER

NCT03440164 - Superior Silybin Bioavailability in Healthy Volunteers | Biotech Hunter | Biotech Hunter